Literature DB >> 20231916

Inference of the haplotype effect in a matched case-control study using unphased genotype data.

Samiran Sinha1, Stephen B Gruber, Bhramar Mukherjee, Gad Rennert.   

Abstract

Typically locus specific genotype data do not contain information regarding the gametic phase of haplotypes, especially when an individual is heterozygous at more than one locus among a large number of linked polymorphic loci. Thus, studying disease-haplotype association using unphased genotype data is essentially a problem of handling a missing covariate in a case-control design. There are several methods for estimating a disease-haplotype association parameter in a matched case-control study. Here we propose a conditional likelihood approach for inference regarding the disease-haplotype association using unphased genotype data arising from a matched case-control study design. The proposed method relies on a logistic disease risk model and a Hardy-Weinberg equilibrium (HWE) among the control population only. We develop an expectation and conditional maximization (ECM) algorithm for jointly estimating the haplotype frequency and the disease-haplotype association parameter(s). We apply the proposed method to analyze the data from the Alpha-Tocopherol, Beta-Carotene Cancer prevention study, and a matched case-control study of breast cancer patients conducted in Israel. The performance of the proposed method is evaluated via simulation studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 20231916      PMCID: PMC2835450          DOI: 10.2202/1557-4679.1079

Source DB:  PubMed          Journal:  Int J Biostat        ISSN: 1557-4679            Impact factor:   0.968


  16 in total

1.  A method for the assessment of disease associations with single-nucleotide polymorphism haplotypes and environmental variables in case-control studies.

Authors:  Lue Ping Zhao; Shuying Sue Li; Najma Khalid
Journal:  Am J Hum Genet       Date:  2003-04-16       Impact factor: 11.025

2.  Inference on haplotype effects in case-control studies using unphased genotype data.

Authors:  Michael P Epstein; Glen A Satten
Journal:  Am J Hum Genet       Date:  2003-11-20       Impact factor: 11.025

3.  Comparison of prospective and retrospective methods for haplotype inference in case-control studies.

Authors:  Glen A Satten; Michael P Epstein
Journal:  Genet Epidemiol       Date:  2004-11       Impact factor: 2.135

Review 4.  Inference of haplotypes from PCR-amplified samples of diploid populations.

Authors:  A G Clark
Journal:  Mol Biol Evol       Date:  1990-03       Impact factor: 16.240

5.  Accounting for haplotype uncertainty in matched association studies: a comparison of simple and flexible techniques.

Authors:  Peter Kraft; David G Cox; Randi A Paynter; David Hunter; Immaculata De Vivo
Journal:  Genet Epidemiol       Date:  2005-04       Impact factor: 2.135

6.  Modeling haplotype block variation using Markov chains.

Authors:  G Greenspan; D Geiger
Journal:  Genetics       Date:  2005-12-15       Impact factor: 4.562

7.  Statistical analysis for haplotype-based matched case-control studies.

Authors:  H Zhang; G Zheng; Z Li
Journal:  Biometrics       Date:  2006-12       Impact factor: 2.571

8.  Haplotype-based association analysis in cohort and nested case-control studies.

Authors:  Jinbo Chen; Nilanjan Chatterjee
Journal:  Biometrics       Date:  2006-03       Impact factor: 2.571

9.  Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population.

Authors:  L Excoffier; M Slatkin
Journal:  Mol Biol Evol       Date:  1995-09       Impact factor: 16.240

10.  Manganese superoxide dismutase (MnSOD) polymorphism, alpha-tocopherol supplementation and prostate cancer risk in the alpha-tocopherol, beta-carotene cancer prevention study (Finland).

Authors:  Karen Woodson; Joseph A Tangrea; Teresa A Lehman; Ramakrishna Modali; Kristin M Taylor; Kirk Snyder; Philip R Taylor; Jarmo Virtamo; Demetrius Albanes
Journal:  Cancer Causes Control       Date:  2003-08       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.